Streetbeat News

Stock Prices

ACXP

Acurx Pharmaceuticals (NASDAQ:ACXP) announced promising data on ibezapolstat, showing its positive effects on the gut microbiome and potential in treating C. difficile infections. The drug demonstrated favorable pharmacokinetics and efficacy against B. anthracis, including resistant strains.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:04 am

LUV

Southwest Airlines has revised its Q3 RASM expectations to increase by 2% to 3%, up from a previous forecast of flat to down 2%. This improvement is attributed to customer reaccommodation from other airlines' cancellations and better industry demand trends.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:01 am

MU

QQQ

SPY

US stocks are set for a strong start with Micron's earnings boosting market momentum. China's economic stimulus and upcoming US economic data are influencing market sentiment. Micron's stock surged over 15% in premarket trading, while SPDR S&P 500 ETF and Invesco QQQ ETF also saw gains.

Portfolio Pulse from Shanthi Rexaline

September 26, 2024 | 10:59 am

BDX

Becton, Dickinson (BD) has announced new data showcasing the effectiveness of its BD HealthSight Diversion Management software in identifying controlled substance diversion in operating rooms. The software led to a 55% increase in charting discrepancies detection and improved efficiency in resolving incidents.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:57 am

KMX

CarMax reported Q2 earnings per share of $0.85, missing the $0.86 estimate, but sales of $7.01 billion beat the $6.79 billion estimate. EPS increased by 13.33% from last year, while sales decreased by 0.86% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:53 am

ACN

Accenture reported its Q4 2024 earnings, with adjusted EPS of $2.79 beating the estimate of $2.77, and sales of $16.406 billion surpassing the expected $16.386 billion.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:41 am

REE

REE Automotive reported a Q2 loss of $(0.97) per share, beating the analyst estimate of $(1.51). The company ended Q2 with $60.5M in liquidity, despite a significant year-over-year increase in losses.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:39 am

ENGN

enGene announced preliminary data from the LEGEND study of Detalimogene Voraplasmid (EG-70) in treating Bacillus Calmette-Guérin-unresponsive, non-muscle invasive bladder cancer with carcinoma in situ, showing a complete response rate of 71%.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:34 am

KTRA

MU

TBIO

Telesis Bio shares surged 109.9% in pre-market trading after announcing a partnership with Beckman Coulter Life Sciences to enhance DNA and mRNA synthesis. Other notable pre-market movers include Micron Technology, which rose 15.5% following strong Q4 results, and Kintara Therapeutics, up 41.8% after adjourning a stockholder meeting.

Portfolio Pulse from Avi Kapoor

September 26, 2024 | 10:31 am

ENTA

Enanta Pharmaceuticals announced that its Phase 2A study of EDP-323 in healthy adults infected with RSV met primary and secondary endpoints, showing significant reductions in viral load and symptoms compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 10:02 am